这场跨界联姻从一开始就充满挑战。公开信息显示，华统集团核心主业为生猪养殖及屠宰加工，是上市 公司华统股份（002840.SZ）的大股东，而高乐股份则深耕玩具制造领域，两者行业属性差异巨大。尽 管华统集团曾计划通过非公开发行股票将持股比例提升至33.85%，进一步巩固控制权，但该计划最终 未能实施，其持股比例始终停留在14%。 智通财经记者 戴高城 11月24日晚间，高乐股份（002348.SZ）一则停牌公告引发资本市场广泛关注。公司公告称，第一大股 东华统集团正筹划转让所持股份或委托表决权，可能导致公司控制权发生变更，股票自11月25日起停 牌，预计停牌不超过2个交易日。 11月24日，高乐股份股价以涨停报收，收盘价4.81元，涨幅10.07%，全天成交额1.26亿元，换手率 2.97%，成交量达26.79万手，市场资金在公告发布前已出现明显异动。 这一股价表现与控制权变更传闻形成呼应，也让市场对后续交易细节更添期待。这意味着，朱俭勇、朱 俭军兄弟掌控的华统集团在入主高乐股份三年后，或将彻底放弃这一跨界标的。 时间回到2022年11月，华统集团以"股份转让+表决权委托"的组合方式高调入主高乐股份。 根据当时公 ...

Core Viewpoint - The announcement of a potential change in control at Gaole Co., Ltd. has attracted significant attention in the capital market, with the first major shareholder, Huadong Group, planning to transfer its shares or delegate voting rights, leading to a stock suspension starting November 25, expected to last no more than two trading days [1] Group 1: Shareholder Changes - Huadong Group is considering transferring its shares or delegating voting rights, which may result in a change of control at Gaole Co., Ltd. [1] - The stock price of Gaole Co., Ltd. closed at 4.81 yuan, with a daily increase of 10.07% and a trading volume of 1.26 billion yuan, indicating significant market activity prior to the announcement [1] - The market is keenly awaiting details of the transaction, as the Huadong Group, controlled by the Zhu brothers, may completely divest from Gaole Co., Ltd. after three years of ownership [1] Group 2: Historical Context - In November 2022, Huadong Group acquired a 21.74% voting control in Gaole Co., Ltd. through a combination of share transfer and voting rights delegation, becoming the controlling shareholder [2] - The initial goal of Huadong Group was to stabilize Gaole Co., Ltd.'s toy business and facilitate its industrial transformation, including a proposed 2 billion yuan solid-state battery project [2] - The merger faced challenges due to the significant industry differences between Huadong Group's core business in pig farming and Gaole Co., Ltd.'s focus on toy manufacturing [2] Group 3: Financial Performance - Gaole Co., Ltd. reported a revenue of 226 million yuan for the third quarter of 2025, a year-on-year increase of 10.06%, but still recorded a net loss of 11.67 million yuan, although this was a 65.91% reduction in losses compared to the previous year [3] - The company achieved a significant net profit of 16.28 million yuan in the third quarter, a year-on-year increase of 936.40%, primarily due to non-recurring gains [3] - Huadong Group's performance has also been under pressure, with a net loss of 5.16 million yuan in the third quarter of 2025, influenced by a downturn in the pig farming industry [3] Group 4: Market Speculation - The market is particularly interested in the identity of the potential buyer and the transfer price, as the announcement did not disclose specific details about the transaction [4] - The previous year saw a more dispersed shareholding structure, which adds uncertainty to the potential change in control [4]

Group 1 - The stock price of Tiankang Biological on July 29 closed at 6.50 yuan, down 0.11 yuan, a decrease of 1.66% from the previous trading day [1] - The trading volume on that day was 293,400 hands, with a transaction amount of 190 million yuan, and a turnover rate of 2.15% [1] - Tiankang Biological's main business includes feed, veterinary drugs, pig farming, and slaughter processing within the agricultural and animal husbandry industry chain [1] Group 2 - The company is a significant agricultural and animal husbandry enterprise in the Xinjiang region, involved in multiple fields such as feed production and animal vaccines [1] - According to the company's statement on the investor interaction platform, the cost of pig farming has decreased to 13 yuan per kilogram by early 2025, which is at an industry-leading level [1] - The company maintains cost control stability through optimizing feed formulas, improving production efficiency, and enhancing industry chain collaboration, while actively expanding sales in markets outside Xinjiang [1]